• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/40

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

40 Cards in this Set

  • Front
  • Back
compensatory changes in response to heart failure?
SNS activation
renin-angiotensin system activation
hypertrophy
detrimental effects of compensatory changes in response to heart failure?
SNS: worsen heart failure;
renin-angiotensin: volume overload and difficulty breathing;
hypertrophy: bad remodeling
ACEI use in chronic heart failure?
decrease symptoms
increase survival
diuretics use in chronic heart failure?
decrease congestive symptoms by decreasing preload;
effect on survival not known
beta blockers use in chronic heart failure?
+ other therapy decrease hospitalization and mortality;
may worsen HF initially with improvements may take months
mechanism of how beta blockers help in heart failure?
interrupt the SNS stimulation to slow disease progression
rationale for spironolactone use in heart failure?
aldosterone has negative effects on heart;
decreased hospitalization and mortality
combination that was shown to increase survival in blacks?
hydralazine and ISDN
pharmacologic treatment of heart failure?
ACEI
diuretics
beta blockers
spironolactone
cardiac glycosides
ARBs
hydralazine + ISDN
eplerenone
use of eplerenone for heart failure?
approve for HF following acute MI in certain cases
additional drugs (parenteral) used in HF?
sodium nitroprusside
dobutamine
dopamine
milrinone
nesiritide
main uses of cardiac glycosides?
heart failure
certain arrhythmias (atrial fib)
only cardiac glycoside available in US?
digoxin
cardiac glycosides aka?
digitalis
mechanism of cardiac glycosides increased contractility?
inhibition of sarcolemmal Na,K-ATPase leading to decreased transmembrane transport of Na and K, increased intracellular Na decreases Na-Ca exchange so there is less Ca available at level of contractile proteins
actions of cardiac glycosides?
increased contractility
vagal stimulation
decreased SNS activity
conduction velocity corresponds to which phase of AP?
slope of phase 0
automaticity relates to which phase of AP?
slope phase 4
important action of cardiac glycosides that for treatment of supraventricular tachyarrhythmias, such as atrial fib?
vagal stimulation to slow conduction through the AV node
cardiac glycosides effects on electrophysiology of heart?
direct and indirect
effect depends on type of cardiac cell
beneficial effect in atrial fib (decreased ventricular rate)
arrhythmias and heart block possible at toxic concentrations
elimination of digoxin and consequence?
2/3 eliminated unchanged in urine so clearance reduced in renal insufficiency and necessary to reduce dose
adverse effects of digitalis?
cardiac toxicity
GI (anorexia, n/v, diarrhea)
CNS (blurred vision, abnormal color vision, confusion, etc)
red flags for digoxin toxicity?
GI symptoms of anorexia, nausea and vomiting, or diarrhea
what population are adverse CNS effects with digoxin seen and what are they?
elderly:
blurred vision
abnormal color vision
confusion
other mental disturbances
treatment for digoxin toxicity?
stop drug
serum K management
arrhythmia and heart block management
ovine digoxin immune fab
electrolyte disturbances increasing risk of digitalis toxicity?
hypokalemia
hypercalcemia
hypomagnesemia
thiazide or loop diuretic + digoxin interaction?
hypokalemia
digoxin + quinidine interaction?
increased plasma digoxin concentration
digoxin + verapamil or amiodarone interaction?
increased plasma digoxin concentration
digoxin + antacids, kaolin-pectin, cholestyramine interaction?
decreased plasma digoxin concentration due to decreased absorption
dobutamine actions?
β1 agonist: increase CO with less reflex tachycardia than occurs with nonselective β agonists
possible adverse effects with dobutamine?
excessive increase in heart rate
arrhythmias
milrinone mechanism?
inhibits phosphodiesterase 3 --> increase cAMP --> increased contractility and vasodilation
milrinone effects in patients with HF?
decreased PWP
decreased peripheral resistance
increased CO
milrinone indications?
only IV for acute heart failure or severe exacerbation of chronic heart failure
nesiritide?
recombinant human B-type natriuretic peptide; hBNP
nesiritide mechanism?
action on guanylate cyclase receptor --> increased cGMP --> smooth muscle relaxation
adverse effects of nesiritide?
hypotension
renal damage and death
indications for nesiritide?
use in certain patients with acute decompensated heart failure
effects of nesiritide?
decreased PWP and dyspnea